Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001628280-19-010974
Filing Date
2019-08-19
Accepted
2019-08-19 20:43:42
Documents
1
Period of Report
2019-08-15

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_156626180538841.html 4  
1 FORM 4 wf-form4_156626180538841.xml 4 37042
  Complete submission text file 0001628280-19-010974.txt   38355
Mailing Address 505 PENOBSCOT DR. REDWOOD CITY CA 94063
Business Address 505 PENOBSCOT DR. REDWOOD CITY CA 94063 855-698-8887
Guardant Health, Inc. (Issuer) CIK: 0001576280 (see all company filings)

EIN.: 454139254 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 8071 Services-Medical Laboratories

Mailing Address 18 ISABELLA AVENUE ATHERTON CA 94027
Business Address
Talasaz AmirAli (Reporting) CIK: 0001753159 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38683 | Film No.: 191037717